Other News

NEW DATA DEMONSTRATES SAFETY AND PERFORMANCE OF CONTINUOUS ASPIRATION THROMBECTOMY WITH PENUMBRA’S INDIGO® SYSTEM CAT™ RX CATHETER IN HIGH-RISK PATIENTS WITH ACUTE CORONARY SYNDROME

Peripheral/Endo by 0 comments

CAT RX established high rates of blood clot removal, blood flow restoration and myocardial perfusion normalization No serious adverse events associated with the use of sustained power aspiration Results of the CHEETAH clinical study were presented at the 2021 Transcatheter Cardiovascular Therapeutics (TCT) conference     ALAMEDA, Calif. – November 5, 2021 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that the CHEETAH clinical study of its Indigo® System CATTM RX Catheter successfully met the primary endpoint and […]

Continue Reading →

Stamford Health Forges New Relationship with Columbia University Irving Medical Center to Expand World-Class Heart Surgery Capabilities

Coronary/Structural Heart by 0 comments

STAMFORD, CT/ NOVEMBER 3, 2021— Stamford Health, known for its award-winning cardiac care through the Heart & Vascular Institute, has expanded its relationship with Columbia University to offer treatment and expertise from Columbia University Irving Medical Center’s nationally recognized heart surgeons. As a result of this new relationship, five of […]

Continue Reading →

Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon

Coronary/Structural Heart by 0 comments

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the start of enrollment in a first in-human trial of the coronary everolimus drug-coated balloon (DCB) being developed by Chansu […]

Continue Reading →

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions

Peripheral/Endo by 0 comments

TEL AVIV, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that […]

Continue Reading →

BD Board Increases Dividend for 50th Consecutive Year, Authorizes 10 Million Additional Share Repurchases

Financial by 0 comments

FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ — The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend will be payable on Dec. 31, 2021 to holders of record on Dec. 10, 2021. The indicated annual dividend […]

Continue Reading →

Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes

Coronary/Structural Heart by 0 comments

ORLANDO, Fla.–(BUSINESS WIRE)–The final results of the PROTECT III and Restore EF prospective studies demonstrate improved outcomes for high-risk PCI patients with the use of Impella heart pumps. The study results were reviewed this morning at Transcatheter Cardiovascular Therapeutics (TCT) 2021, the annual scientific symposium of the Cardiovascular Research Foundation, by Gregg […]

Continue Reading →

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Coronary/Structural Heart by 0 comments

New data from Medtronic Patient Preference study presented at TCT 2021; Medtronic adds to its clinical leadership for renal denervation with launch of the SPYRAL AFFIRM study DUBLIN and ORLANDO, Fla., Nov. 4, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced findings from a new study of the Patient […]

Continue Reading →

Vascular Therapies Announces Presentation of Phase 3 Clinical Trial Results at the American Society of Nephrology Meeting

Peripheral/Endo by 0 comments

– Sirogen™ Shows Encouraging AV Fistula Outcomes in Elderly End-Stage Renal Disease Patients – CRESSKILL, N.J., Nov. 4, 2021 /PRNewswire/ — Vascular Therapies, a privately held biotechnology company is developing Sirogen™, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today, the company announced the presentation […]

Continue Reading →

BioSig Expands its Installation Base in Texas

Rhythm by 0 comments

Signs a new installation agreement with high-volume center in San Antonio Westport, CT, Nov. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]

Continue Reading →

PLx Pharma Inc. Announces New Scientific Data Available Evaluating the Pharmacologic Profile of FDA-Approved VAZALORE 81 mg Liquid-Filled Aspirin Capsules

Coronary/Structural Heart by 0 comments

— VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition — — VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent with VAZALORE 325 mg — — Findings presented at TCT meeting earlier today — SPARTA, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” […]

Continue Reading →
1 … 677 678 679 680 681 … 1,329